UltraSight has collaborated with the Mayo Clinic to advance cardiac care using AI in point-of-care ultrasound (PoCUS).
The partnership aims to develop algorithms for the analysis and interpretation of cardiac ultrasound images, as well as create a comprehensive solution and decision support system.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
This will enable healthcare providers to make more informed diagnoses and treatment decisions with the help of PoCUS devices.
UltraSight CEO Davidi Vortman said: “UltraSight Real-time Guidance software harnesses the power of AI to allow more medical practitioners to capture images with confidence.
“However, obtaining diagnostic quality cardiac images at the patient point of care is only the first step needed to increase patient access to quality care. We firmly believe that point-of-care ultrasound, when enhanced by the capabilities of AI, holds the potential to optimise patient care.
“Through this collaboration, we plan to enhance our solution to detect and manage cardiac conditions in a more scalable and cost-effective way, ultimately helping more patients receive timely treatment.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataMayo Clinic has also invested in UltraSight and now holds a financial interest in the technology being developed.
It has stated that any revenue generated from this venture will be reinvested into its non-profit mission, which focuses on patient care, education, and research.
Mayo Clinic Platform president John Halamka said: “We know that over the next decade, training programs around the world will not graduate enough specialists and technologists to meet the demands of an ageing population.
“The best option in our toolkit is to embrace AI in a way that democratizes access to knowledge. Mayo Clinic and UltraSight will work together to enable a wider spectrum of caregivers to obtain cardiac ultrasound data and understand the results, serving many more patients globally.”
In April 2024, Exact Sciences and Mayo Clinic teamed up to provide advanced cancer testing to patients, including the OncoExTra and Riskguard tests.
